Susquehanna International Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
406,202
-231,580
| -36% | -$1.08M | ﹤0.01% | 2351 |
|
|
2025
Q1 | $3.5M | Buy |
637,782
+530,438
| +494% | +$2.91M | ﹤0.01% | 1598 |
|
|
2024
Q4 | $364K | Buy |
107,344
+27,429
| +34% | +$93K | ﹤0.01% | 4496 |
|
|
2024
Q3 | $228K | Buy |
79,915
+47,669
| +148% | +$136K | ﹤0.01% | 4651 |
|
|
2024
Q2 | $72.6K | Buy |
32,246
+4,856
| +18% | +$10.9K | ﹤0.01% | 5190 |
|
|
2024
Q1 | $60.5K | Sell |
27,390
-135,839
| -83% | -$300K | ﹤0.01% | 5133 |
|
|
2023
Q4 | $384K | Buy |
163,229
+56,998
| +54% | +$134K | ﹤0.01% | 4220 |
|
|
2023
Q3 | $198K | Sell |
106,231
-17,441
| -14% | -$32.4K | ﹤0.01% | 4554 |
|
|
2023
Q2 | $324K | Sell |
123,672
-9,721
| -7% | -$25.5K | ﹤0.01% | 4138 |
|
|
2023
Q1 | $217K | Buy |
133,393
+69,824
| +110% | +$114K | ﹤0.01% | 4781 |
|
|
2022
Q4 | $84.5K | Sell |
63,569
-32,218
| -34% | -$42.9K | ﹤0.01% | 5019 |
|
|
2022
Q3 | $149K | Buy |
95,787
+32,395
| +51% | +$50.4K | ﹤0.01% | 5023 |
|
|
2022
Q2 | $98K | Sell |
63,392
-359,784
| -85% | -$556K | ﹤0.01% | 5012 |
|
|
2022
Q1 | $1.08M | Sell |
423,176
-411,360
| -49% | -$1.05M | ﹤0.01% | 2713 |
|
|
2021
Q4 | $2.45M | Buy |
834,536
+225,009
| +37% | +$659K | ﹤0.01% | 1757 |
|
|
2021
Q3 | $1.49M | Buy |
609,527
+528,795
| +655% | +$1.3M | ﹤0.01% | 2265 |
|
|
2021
Q2 | $329K | Buy |
+80,732
| New | +$329K | ﹤0.01% | 4360 |
|
|
2021
Q1 | – | Sell |
-145,255
| Closed | -$715K | – | 5831 |
|
|
2020
Q4 | $715K | Buy |
+145,255
| New | +$715K | ﹤0.01% | 2997 |
|
|
2020
Q3 | – | Sell |
-12,392
| Closed | -$33K | – | 5057 |
|
|
2020
Q2 | $33K | Sell |
12,392
-4,126
| -25% | -$11K | ﹤0.01% | 4082 |
|
|
2020
Q1 | $32K | Buy |
+16,518
| New | +$32K | ﹤0.01% | 4280 |
|
|
2019
Q4 | – | Sell |
-20,039
| Closed | -$197K | – | 4920 |
|
|
2019
Q3 | $197K | Buy |
20,039
+9,700
| +94% | +$95.4K | ﹤0.01% | 3853 |
|
|
2019
Q2 | $118K | Buy |
+10,339
| New | +$118K | ﹤0.01% | 4111 |
|